Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

4850 ARTíCULOS , VIENDO DEL 1891 AL 1905

PUBMED

Prediction of Freezing of Gait in Patients With Parkinson's Disease by Identifying Impaired Gait Patterns

Zhang Y, Yan W, Yao Y, Ahmed JB, Tan Y, Gu D.

IEEE Trans Neural Syst Rehabil Eng. 2020 Mar;28(3):591-600. doi: 10.1109/TNSRE.2020.2969649. Epub 2020 Jan 27.

0

0

0

PUBMED

Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's

Higazy IM.

Saudi Pharm J. 2020 Jan;28(1):33-57. doi: 10.1016/j.jsps.2019.11.004. Epub 2019 Nov 13.

0

0

0

PUBMED

Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease

Ueno SI, Hatano T, Okuzumi A, Saiki S, Oji Y, Mori A, Koinuma T, Fujimaki M, Takeshige-Amano H, Kondo A, Yoshikawa N, Nojiri T, Kurano M, Yasukawa K, Yatomi Y, Ikeda H, Hattori N.

Ann Clin Transl Neurol. 2020 Mar;7(3):307-317. doi: 10.1002/acn3.50990. Epub 2020 Feb 14.

0

0

0

PUBMED

Role of α-Synuclein Regions in Nucleation and Elongation of Amyloid Fiber Assembly

Gallardo J, Escalona-Noguero C, Sot B.

ACS Chem Neurosci. 2020 Mar 18;11(6):872-879. doi: 10.1021/acschemneuro.9b00527. Epub 2020 Mar 4.

0

0

0

PUBMED

The relationship between Parkinson's disease symptoms and caregiver quality of life

Henry RS, Lageman SK, Perrin PB.

Rehabil Psychol. 2020 May;65(2):137-144. doi: 10.1037/rep0000313. Epub 2020 Feb 17.

0

0

0

PUBMED

Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies

Fayyad M, Majbour NK, Vaikath NN, Erskine D, El-Tarawneh H, Sudhakaran IP, Abdesselem H, El-Agnaf OMA.

Neurosci Lett. 2020 Apr 23;725:134899. doi: 10.1016/j.neulet.2020.134899. Epub 2020 Mar 7.

0

0

0

PUBMED

Self-reported rates of impulsivity in Parkinson's Disease

Aumann MA, Stark AJ, Hughes SB, Lin YC, Kang H, Bradley E, Zald DH, Claassen DO.

Ann Clin Transl Neurol. 2020 Apr;7(4):437-448. doi: 10.1002/acn3.51016. Epub 2020 Mar 29.

0

0

0

PUBMED

Gait Rhythm Dynamics for Neuro-Degenerative Disease Classification via Persistence Landscape- Based Topological Representation

Yan Y, Ivanov K, Mumini Omisore O, Igbe T, Liu Q, Nie Z, Wang L.

Sensors (Basel). 2020 Apr 3;20(7):2006. doi: 10.3390/s20072006.

0

0

0

PUBMED

miR-7 Controls the Dopaminergic/Oligodendroglial Fate through Wnt/β-catenin Signaling Regulation

Adusumilli L, Facchinello N, Teh C, Busolin G, Le MT, Yang H, Beffagna G, Campanaro S, Tam WL, Argenton F, Lim B, Korzh V, Tiso N.

Cells. 2020 Mar 13;9(3):711. doi: 10.3390/cells9030711.

0

0

0

PUBMED

Nonmotor-Related Quality of Life in Parkinson's Patients with Subjective Memory Complaints: Comparison with PDQ-39

Jenny AL, Meyer A, Handabaka I, Calabrese P, Fuhr P, Gschwandtner U.

Parkinsons Dis. 2020 Apr 20;2020:7953032. doi: 10.1155/2020/7953032. eCollection 2020.

0

0

0

PUBMED

Local White Matter Fiber Clustering Differentiates Parkinson's Disease Diagnoses

Feng Y, Yan W, Wang J, Song J, Zeng Q, Zhao C.

Neuroscience. 2020 May 21;435:146-160. doi: 10.1016/j.neuroscience.2020.03.049. Epub 2020 Apr 6.

0

0

0

PUBMED

α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb

Stevenson TJ, Murray HC, Turner C, Faull RLM, Dieriks BV, Curtis MA.

Sci Rep. 2020 Apr 21;10(1):6682. doi: 10.1038/s41598-020-63412-x.

0

0

0

PUBMED

The Effect of Unilateral Subthalamic Nucleus Deep Brain Stimulation on Contralateral Subthalamic Nucleus Local Field Potentials

Hasegawa H, Fischer P, Tan H, Pogosyan A, Samuel M, Brown P, Ashkan K.

Neuromodulation. 2020 Jun;23(4):509-514. doi: 10.1111/ner.13155. Epub 2020 Apr 12.

0

0

0

PUBMED

Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases

Krahn AI, Wells C, Drewry DH, Beitel LK, Durcan TM, Axtman AD.

ACS Chem Neurosci. 2020 Jun 11. doi: 10.1021/acschemneuro.0c00176. Online ahead of print.

0

0

0

PUBMED

Qi-activating quercetin alleviates mitochondrial dysfunction and neuroinflammation in vivo and in vitro

Kang S, Piao Y, Kang YC, Lim S, Pak YK.

Arch Pharm Res. 2020 May;43(5):553-566. doi: 10.1007/s12272-020-01238-x. Epub 2020 May 25.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy